Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 751 AL 765

One-year Outcome of Shanghai Mild Cognitive Impairment Cohort Study

Zhou B, Zhao Q, Kojima S, Ding D, Higashide S, Nagai Y, Guo Q, Kagimura T, Fukushima M, Hong Z.

Curr Alzheimer Res. 2019;16(2):156-165. doi: 10.2174/1567205016666181128151144.

In-Out-Test: A New Paradigm for Sorting the Wheat from the Chaff in Prodromal Alzheimer's Disease

Torrealba E, Garcia-Morales P, Cejudo JC, Diaz M, Rodriguez-Esparragon F, Fabre O, Mesa-Herrera F, Marin R, Sanchez-Garcia F, Rodriguez-Perez A, Gramunt N.

J Alzheimers Dis. 2019;67(1):265-277. doi: 10.3233/JAD-171007.

Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research

Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Vergallo A, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS.

J Prev Alzheimers Dis. 2019;6(1):2-15. doi: 10.14283/jpad.2018.43.

Getting to the Heart of Alzheimer Disease

Tublin JM, Adelstein JM, Del Monte F, Combs CK, Wold LE.

Circ Res. 2019 Jan 4;124(1):142-149. doi: 10.1161/CIRCRESAHA.118.313563.

Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis

Bradburn S, Murgatroyd C, Ray N.

Ageing Res Rev. 2019 Mar;50:1-8. doi: 10.1016/j.arr.2019.01.002. Epub 2019 Jan 2.

Defining Cognitive Reserve and Implications for Cognitive Aging

Pettigrew C, Soldan A.

Curr Neurol Neurosci Rep. 2019 Jan 9;19(1):1. doi: 10.1007/s11910-019-0917-z.

Copper in Glucose Intolerance, Cognitive Decline, and Alzheimer Disease

Squitti R, Mendez A, Ricordi C, Siotto M, Goldberg R.

Alzheimer Dis Assoc Disord. 2019 Jan-Mar;33(1):77-85. doi: 10.1097/WAD.0000000000000280.

"Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia"

Jagust W, Jack CR Jr, Bennett DA, Blennow K, Haeberlein SB, Holtzman DM, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Sperling R.

Alzheimers Dement. 2019 Jan;15(1):153-157. doi: 10.1016/j.jalz.2018.11.002.

Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis

Parnetti L, Chipi E, Salvadori N, D'Andrea K, Eusebi P.

Alzheimers Res Ther. 2019 Jan 15;11(1):7. doi: 10.1186/s13195-018-0459-7.

Sleep-wake regulation and the hallmarks of the pathogenesis of Alzheimer's disease

Van Egroo M, Narbutas J, Chylinski D, Villar González P, Maquet P, Salmon E, Bastin C, Collette F, Vandewalle G.

Sleep. 2019 Apr 1;42(4):zsz017. doi: 10.1093/sleep/zsz017.

Implications of sleep disturbance and inflammation for Alzheimer's disease dementia

Irwin MR, Vitiello MV.

Lancet Neurol. 2019 Mar;18(3):296-306. doi: 10.1016/S1474-4422(18)30450-2. Epub 2019 Jan 17.

Type of memory and emotional valence in healthy aging, mild cognitive impairment, and Alzheimer's disease

Meléndez JC, Escudero J, Satorres E, Pitarque A.

Psicothema. 2019 Feb;31(1):60-65. doi: 10.7334/psicothema2018.181.

The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease

Rubin LH, Sundermann EE, Moore DJ.

J Neurovirol. 2019 Oct;25(5):661-672. doi: 10.1007/s13365-018-0702-9. Epub 2019 Jan 22.

Neurodegenerative Dementias: Improving Brain Health to Decrease Risk

Bateman JR, Hurley RA, Taber KH.

J Neuropsychiatry Clin Neurosci. 2019 Winter;31(1):A4-5. doi: 10.1176/appi.neuropsych.18110287.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias